US approves first gene therapy for rare genetic disease

Kyowa Kirin

18/03/2024 18:08

March 18 (Reuters) - The U.S. Food and Drug
Administration said on Monday it had approved UK-based Orchard
Therapeutics' gene therapy for the treatment of children with a
rare hereditary disease called metachromatic leukodystrophy
(MLD).        

 (Reporting by Mariam Sunny in Bengaluru; Editing by Sriraj
Kalluvila)
 ((Mariam.ESunny@thomsonreuters.com;))